© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Stemtech Corporation (STEK) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 8.91M |
| Sep 10, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 15.8M |
| Sep 09, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 230K |
| Sep 08, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 56.53K |
| Sep 04, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 132K |
| Sep 03, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 457K |
| Sep 02, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 3.47M |
| Sep 01, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 90K |
| Aug 31, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 1.1M |
| Aug 28, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 395.15K |
| Aug 27, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 800K |
| Aug 25, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 760.01K |
| Aug 24, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 3.38M |
| Aug 21, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 570.5K |
| Aug 20, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 65.33M |
| Aug 19, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 334.68K |
| Aug 17, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 5.13M |
| Aug 14, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 2.91M |
| Aug 13, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 47.74K |
| Aug 12, 2026 | 0.00 | 0.00 | 0.00 | 0.00 | 10K |
Stemtech Corporation is a pioneering company specializing in stem cell nutrition. It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality. The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
| Employees | 1 |
| Beta | 2.58 |
| Sales or Revenue | $4.56M |
| 5Y Sales Change% | -0.952% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |